...
首页> 外文期刊>Pediatric nephrology: journal of the International Pediatric Nephrology Association >An open-label, multicenter, multiple-dose study to determine the optimum starting dose of CERA (continuous erythropoietin receptor activator - methoxy polyethylene glycol-epoetin beta) for maintenance treatment of anemia in pediatric patients with chronic kidney disease (CKD) on hemodialysis (HD) (NH19707, NCT00717366)
【24h】

An open-label, multicenter, multiple-dose study to determine the optimum starting dose of CERA (continuous erythropoietin receptor activator - methoxy polyethylene glycol-epoetin beta) for maintenance treatment of anemia in pediatric patients with chronic kidney disease (CKD) on hemodialysis (HD) (NH19707, NCT00717366)

机译:一项开放性,多中心,多剂量研究,用于确定CERA(连续性促红细胞生成素受体激活剂-甲氧基聚乙二醇-表皮素β)的最佳起始剂量,用于维持治疗慢性肾脏病(CKD)的小儿血液透析患者的贫血( HD)(NH19707,NCT00717366)

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号